Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07818486) titled 'A Study of BL-M08D1 in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma and Other Solid Tumors' on Sept. 8.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Sichuan Baili Pharmaceutical Co., Ltd.
Condition:
Nasopharyngeal Carcinoma (NPC)
Solid Tumors
Intervention:
Drug: BL-M08D1
Recruitment Status: Not recruiting
Phase: Phase 1/Phase 2
Date of First Enrollment: September 2026
Target Sample Size: 30
Countries of Recruitment:
China
To know more, visit https://clin...